Patients with Hepatitis C, infected doctor denies allegations

A doctor from Bavaria, denies that his patients with Hepatitis C infected. The anaesthetist, too, suffered from the disease and to self-injected medications and the same injection in patients have used. His lawyers disagree with this view, as the “Süddeutsche Zeitung” and “die Welt” reports on agreement.

Accordingly, your client have used syringes from the clinic, which had been used in operations. The anesthesiologist did not use the syringes but again in patients and could not thus be the source of infection.

He had to learn in may of the disease and is now cured. “There is no plausible explanation of how the infection occurs to be,” said Christian kąty wrocławskie of the firm of Herrmann and colleagues to the “world”.

In the meantime, the physician no longer works in the Danube-Ries clinic in Donauwörth. As the allegations against him were known, wrote to the health Department all patients treated by the doctor. In the meantime, the Hepatitis has been demonstrated C Virus in 51 Affected.

Diagnosis Of Hepatitis C

Hepatitis C is a liver inflammation caused by Hepatitis C virus. Usually, the infection is transmitted only through blood contact. A risk of Contagion for example, in the case of unhygienic conditions during the tattooing process. In Germany, 400,000 to 500,000 people with Hepatitis C are infected with Virus.

Hepatitis C infection leads according to the German liver help in the beginning, very rarely to complaints, at 20 to 50 per cent, it heals within the first half of the year. In the remainder of the Affected the Virus remains in the body, you develop chronic inflammation of the liver. Without treatment, consequences, such as cirrhosis or liver cancer threaten late.

Drugs are expensive

There is a therapy available on the market that can cure Hepatitis C in a majority of patients, and with relatively few side effects. The drug, however, is extremely expensive. Also, Doctors in Germany have a hard time therefore, sometimes, to prescribe the substance.

Aid organizations have appealed before the European patent office in Munich-an opposition against the Patent of the pharmaceutical company Gilead, to the active ingredient, in order to make it more available to patients.

Source: Read Full Article